Description:

Size: 100ul

Catalog no.: bs-0007R-A594

Price: 380 EUR

Product details

Gene ID Number

133

Modification Site

None

Swiss Prot

P35318

Subcellular location

Secreted

Tested applications

IF(IHC-P)

French translation

anticorps

Crossreactivity

Human, Rat

Modification

Unmodified

Clonality

Polyclonal

Immunogen range

115-146/185

Excitation emission

590nm/617nm

Concentration

1ug per 1ul

Target Antigen

Adrenomedullin

Conjugated with

ALEXA FLUOR® 594

Conjugated

Alexa conjugate 1

Recommended dilutions

IF(IHC-P)(1:50-200)

Clone

Polyclonal antibody

Purification

Purified by Protein A.

Category

Conjugated Primary Antibodies

Synonyms

AM; PAMP; ADM; Adrenomedullin

Conjugation

Alexa Fluor,ALEXA FLUOR® 594

Host Organism

Rabbit (Oryctolagus cuniculus)

Also known as

Anti-Adrenomedullin PAb ALEXA FLUOR 594

Specificity

This is a highly specific antibody against Adrenomedullin.

Long name

Adrenomedullin Polyclonal Antibody, ALEXA FLUOR 594 Conjugated

Cross-reactive species details

Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.

Source

This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human Adrenomedullin

Storage conditions

Store this antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Keep refrigerated at 2 to 8 degrees Celcius for up to one year.

Properties

For facs or microscopy Alexa 1 conjugate.If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies. ALEXA FLUOR they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

Background of the antigen

AM and PAMP are potent hypotensive and vasodilatator agents. Numerous actions have been reported most related to the physiologic control of fluid and electrolyte homeostasis. In the kidney, am is diuretic and natriuretic, and both am and pamp inhibit aldosterone secretion by direct adrenal actions. In pituitary gland, both peptides at physiologically relevant doses inhibit basal ACTH secretion. Both peptides appear to act in brain and pituitary gland to facilitate the loss of plasma volume, actions which complement their hypotensive effects in blood vessels.